Barrowcliffe Susan E.

General Manager, Europe at Aimmune Therapeutics, Inc.

Sold, on record
$6.1M
Dollars the filings state
Form 4 sales
9
Latest Nov 19, 2018
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Aimmune Therapeutics, Inc.Unusual
    Nov 11, 2016 2016

    Sold 20,000 shares at $25.00 ($500k)

    Barrowcliffe Susan E., General Manager, Europe

    Sold 100% of holdings ($500k position)0 shares leftFiling

  2. 2 Form 4 sale Aimmune Therapeutics, Inc.Unusual
    Jul 3, 2017 +234 days

    Sold 15,000 shares at $20.26 ($304k)

    Barrowcliffe Susan E., General Manager, Europe

    Sold 100% of holdings ($304k position)0 shares leftFiling

  3. 3 Form 4 sale Aimmune Therapeutics, Inc.Unusual
    Jul 25, 2017 +22 days

    Sold 6,110 shares at $22.00 ($134k)

    Barrowcliffe Susan E., General Manager, Europe

    Sold 100% of holdings ($134k position)0 shares left0.4x usual sizeFiling

  4. 4 Form 4 sale Aimmune Therapeutics, Inc.Unusual
    Jul 27, 2017 +2 days

    Sold 500 shares at $22.00 ($11k)

    Barrowcliffe Susan E., General Manager, Europe

    Sold 100% of holdings ($11k position)0 shares left0x usual sizeFiling

  5. 5 Form 4 sale Aimmune Therapeutics, Inc.Unusual
    Sep 6, 2017 +41 days

    Sold 18,390 shares at $22.00 ($405k)

    Barrowcliffe Susan E., General Manager, Europe

    Sold 100% of holdings ($405k position)0 shares left1.2x usual sizeFiling

  6. 6 Form 4 sale Aimmune Therapeutics, Inc.Unusual
    Sep 25, 2017 +19 days

    Sold 20,000 shares at $25.00 ($500k)

    Barrowcliffe Susan E., General Manager, Europe

    Sold 100% of holdings ($500k position)0 shares left1.3x usual sizeFiling

  7. 7 Form 4 sale Aimmune Therapeutics, Inc.Unusual
    Jan 2, 2018 +99 days

    Sold 75,000 shares at $37.14 ($2.8M)

    Barrowcliffe Susan E., General Manager, Europe

    Sold 100% of holdings ($2.8M position)0 shares left5x usual sizeFiling

  8. 8 Form 4 sale Aimmune Therapeutics, Inc.Unusual
    Nov 19, 2018 +321 days

    Sold 40,000 shares at $30.04 ($1.2M)

    Barrowcliffe Susan E., General Manager, Europe

    Sold 81% of holdings ($1.5M position)9,375 shares left2.4x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (9)

Form 144 notices and Form 4 sales by Barrowcliffe Susan E.
Source
Nov 19, 2018Nov 21, 2018Aimmune Therapeutics, Inc.General Manager, EuropeForm 4 sale40,000$1.2M81.0%UnusualSEC
Jan 2, 2018Jan 4, 2018Aimmune Therapeutics, Inc.General Manager, EuropeForm 4 sale75,000$2.8M100.0%UnusualSEC
Sep 25, 2017Sep 27, 2017Aimmune Therapeutics, Inc.General Manager, EuropeForm 4 sale20,000$500k100.0%UnusualSEC
Sep 6, 2017Sep 7, 2017Aimmune Therapeutics, Inc.General Manager, EuropeForm 4 sale18,390$405k100.0%UnusualSEC
Jul 27, 2017Jul 31, 2017Aimmune Therapeutics, Inc.General Manager, EuropeForm 4 sale500$11k100.0%UnusualSEC
Jul 25, 2017Jul 25, 2017Aimmune Therapeutics, Inc.General Manager, EuropeForm 4 sale6,110$134k100.0%UnusualSEC
Jul 3, 2017Jul 6, 2017Aimmune Therapeutics, Inc.General Manager, EuropeForm 4 sale15,000$304k100.0%UnusualSEC
Nov 11, 2016Nov 15, 2016Aimmune Therapeutics, Inc.General Manager, EuropeForm 4 sale20,000$500k100.0%UnusualSEC
Nov 8, 2016Nov 10, 2016Aimmune Therapeutics, Inc.General Manager, EuropeForm 4 sale15,000$300k100.0%UnusualSEC